Relationship between QT Interval Length and Arterial Stiffness in Systemic Lupus Erythematosus (SLE): A Cross-Sectional Case-Control Study
Metadatos
Mostrar el registro completo del ítemAutor
Rivera López, Ricardo Francisco; Jiménez Jáimez, Juan; Sabio, José Mario; Zamora-Pasadas, Mónica; Vargas-Hitos, José Antonio; Martínez Bordonado, Josefa; Navarrete-Navarrete, Nuria; Rivera Fernández, Ricardo; Sánchez-Cantalejo Ramírez, Emilio; Jiménez Alonso, Juan FranciscoEditorial
Plos One
Fecha
2016-04-11Referencia bibliográfica
Rivera-López R, Jiménez-Jáimez J, Sabio JM, Zamora-Pasadas M, Vargas-Hitos JA, Martínez-Bordonado J, et al. (2016) Relationship between QT Interval Length and Arterial Stiffness in Systemic Lupus Erythematosus (SLE): A Cross-Sectional Case-Control Study. PLoS ONE 11(4): e0152291. doi:10.1371/journal.pone.0152291
Resumen
Introduction and Objectives
The QT interval on the electrocardiogram has been shown to be longer in patients with systemic
lupus erythematosus (SLE) compared to that of the general population. The clinical
significance of this finding is unknown. The aim of this study was to assess the relationship
between QT interval and subclinical atherosclerosis, measured by carotid-femoral pulsewave
velocity.
Material and Methods
93 patients with SLE and 109 healthy women with similar basal characteristics were studied.
All patients underwent a 12- lead electrocardiogram, and corrected QT interval (QTc)
was measured using the Bazett’s formula. The presence of atherosclerosis was evaluated
by carotid-femoral pulse-wave velocity.
Results
Clinical basal characteristics were similar in both groups. QTc interval was 415±21.4 milliseconds
in all patients, and 407±19.1 milliseconds in the control group (p = 0.007). There
was a positive correlation between QTc interval and carotid-femoral pulse-wave velocity
(r = 0.235; p = 0.02) in patients with SLE. This association was independent of hypertension
and age in a multivariate analysis.
Conclusion
QTc interval measured by electrocardiogram is prolonged in SLE patients; it is related to
subclinical atherosclerosis, measured by carotid-femoral pulse-wave velocity. This measure may help stratify risk in routine clinical practice and select the patients that might
benefit from a more aggressive therapy in the prevention of cardiovascular events.